BMO Cuts Cardiome Pharma (CRME) to Market Perform Amid Vernakalant News
Go back to BMO Cuts Cardiome Pharma (CRME) to Market Perform Amid Vernakalant News| CARDIOME PHARMA (NASDAQ: CRME) | Delayed: 2.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.33 | 52 Week High | $9.21 | |||
| Open | $28.95 | 52 Week Low | $2.35 | |||
| Day High | $2.33 | P/E | N/A | |||
| Day Low | $2.33 | EPS | $0.00 | |||
| Volume | 525 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 135.97 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $135.97 | 52 Week High | $65.46 | |||
| Open | $135.97 | 52 Week Low | $47.97 | |||
| Day High | $135.97 | P/E | 92.50 | |||
| Day Low | $135.97 | EPS | $1.47 | |||
| Volume | 611 | |||||
